235 related articles for article (PubMed ID: 29233548)
1. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).
Morrison VA; McCall L; Muss HB; Jatoi A; Cohen HJ; Cirrincione CT; Ligibel JA; Lafky JM; Hurria A
J Geriatr Oncol; 2018 May; 9(3):228-234. PubMed ID: 29233548
[TBL] [Abstract][Full Text] [Related]
2. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
[TBL] [Abstract][Full Text] [Related]
3. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.
Rosner GL; Hargis JB; Hollis DR; Budman DR; Weiss RB; Henderson IC; Schilsky RL
J Clin Oncol; 1996 Nov; 14(11):3000-8. PubMed ID: 8918498
[TBL] [Abstract][Full Text] [Related]
4. Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
Furlanetto J; Eiermann W; Marmé F; Reimer T; Reinisch M; Schmatloch S; Stickeler E; Thomssen C; Untch M; Denkert C; von Minckwitz G; Lederer B; Nekljudova V; Weber K; Loibl S; Möbus V
Ann Oncol; 2016 Nov; 27(11):2053-2059. PubMed ID: 27502721
[TBL] [Abstract][Full Text] [Related]
5. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
6. Are medical oncologists biased in their treatment of the large woman with breast cancer?
Madarnas Y; Sawka CA; Franssen E; Bjarnason GA
Breast Cancer Res Treat; 2001 Mar; 66(2):123-33. PubMed ID: 11437098
[TBL] [Abstract][Full Text] [Related]
7. Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas A; Foukakis T; Moebus V; Greil R; Bengtsson NO; Steger GG; Untch M; Johansson H; Hellström M; Malmström P; Gnant M; Loibl S; Bergh J
Ann Oncol; 2019 Jan; 30(1):109-114. PubMed ID: 30357310
[TBL] [Abstract][Full Text] [Related]
8. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.
Lote H; Sharp A; Redana S; Papadimitraki E; Capelan M; Ring A
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):597-603. PubMed ID: 26936608
[TBL] [Abstract][Full Text] [Related]
9. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer Outcome.
Lomma C; Chih H; Chan A
Clin Breast Cancer; 2023 Jul; 23(5):491-499. PubMed ID: 37169686
[TBL] [Abstract][Full Text] [Related]
11. Myelosuppression by chemotherapy in obese patients with gynecological cancers.
Kamimura K; Matsumoto Y; Zhou Q; Moriyama M; Saijo Y
Cancer Chemother Pharmacol; 2016 Sep; 78(3):633-41. PubMed ID: 27485538
[TBL] [Abstract][Full Text] [Related]
12. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
[TBL] [Abstract][Full Text] [Related]
13. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy.
Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS
BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616
[TBL] [Abstract][Full Text] [Related]
14. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.
Dickson TM; Kusnierz-Glaz CR; Blume KG; Negrin RS; Hu WW; Shizuru JA; Johnston LL; Wong RM; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 1999; 5(5):299-305. PubMed ID: 10534060
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
Schwartz J; Toste B; Dizon DS
Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
[TBL] [Abstract][Full Text] [Related]
17. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087
[TBL] [Abstract][Full Text] [Related]
18. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy.
Ding PQ; Batra A; Xu Y; McKinnon GP; Cheung WY
Clin Colorectal Cancer; 2020 Sep; 19(3):209-218. PubMed ID: 32291245
[TBL] [Abstract][Full Text] [Related]
19. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
